Previous close | 15.50 |
Open | 14.35 |
Bid | 14.30 |
Ask | 16.20 |
Strike | 160.00 |
Expiry date | 2024-10-18 |
Day's range | 14.35 - 14.35 |
Contract range | N/A |
Volume | |
Open interest | 54 |
Johnson & Johnson (JNJ) closed the most recent trading day at $145.28, moving +0.58% from the previous trading session.
Data from a late-stage study shows that treatment with J&J's (JNJ) experimental drug met all study endpoints in depression patients with insomnia symptoms.
Merck's (MRK) acquisition of EyeBio is set to add the latter's lead pipeline candidate, Restoret, a novel Wnt agonist antibody being developed for treating retinal diseases.